MyMicrobiome is proud to introduce the new MyMicrobiome Derm Standard 26.10 Acne, designed to evaluate cosmetic products for their impact on the delicate microbiome of acne-prone skin. As the most common skin condition worldwide, acne requires targeted skin care. The new acne standard ensures that acne products support microbial balance rather than disrupting it.
Acne is a complex skin condition influenced by the balance of the skin’s microbiome. A key microorganism involved is Cutibacterium acnes (C. acnes)—a naturally occurring bacterium on the skin. While often associated with acne, not all C. acnes strains are harmful. Some contribute to inflammation and breakouts, while others help maintain a healthy skin barrier.
Dr. Neumann, Co-Founder and Chief Scientific Officer of MyMicrobiome, explains:
“Acne isn’t just about the presence of C. acnes—it’s about an imbalance in the skin’s microbial community. A lack of diversity and an overgrowth of inflammatory strains can trigger breakouts. That’s why preserving a balanced and diverse microbiome is essential for healthy skin.”
Derm Standard 26.10 Acne involves five distinct tests that assess whether a cosmetic product can inhibit the growth of harmful C. acnes strains while leaving beneficial ones unharmed. These tests are conducted in qualified laboratories in Germany and Switzerland. Products that pass all tests will be awarded the Microbiome-friendly Derm Seal, a mark of trust and scientific validation.
Learn more at www.mymicrobiome.info
